title: Is it Possible to Predict The Market Access of a New Pharmaceutical in Germany? A Systematic Evaluation of Federal Joint Committee Decisions on Early Benefit Assessments According to The German Law For Reforming The Market of Pharmaceuticals.
authors.affiliation: AHEAD GmbH, Loerrach, Germany.
authors.forename: B
authors.initials: B
authors.lastname: Schwander
authors.affiliation: Outcomes International, Basel, Switzerland.
authors.forename: K
authors.initials: K
authors.lastname: Banz
authors.affiliation: University of Freiburg, Freiburg, Germany.
authors.forename: K
authors.initials: K
authors.lastname: Kaier
authors.affiliation: MArS Market Access & Pricing Strategy GmbH, Weil am Rhein, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Walzer